# Executive Summary: Dosing Guidance SME Sign-Off Request

**One-Page Overview for Pharmacologist Review**

---

## 🎯 What We Built

An AI-powered pharmacogenomics dosing guidance system that:
- Identifies high-risk DPYD/TPMT/UGT1A1 variants
- Recommends CPIC-aligned dose adjustments
- Flags patients at risk for severe toxicity BEFORE treatment

---

## 📊 Validation Results (N=59 cases)

| Metric | Result | Target | Status |
|--------|--------|--------|--------|
| **Sensitivity** | 100% | ≥85% | ✅ All 6 toxicity cases caught |
| **Specificity** | 100% | ≥65% | ✅ Zero false positives |
| **Sample Size** | 59 | ≥50 | ✅ Exceeded |
| **Genes** | 3 | ≥3 | ✅ DPYD, TPMT, UGT1A1 |

---

## ✅ Key Clinical Scenarios Handled Correctly

| Scenario | Our Recommendation | Outcome |
|----------|-------------------|---------|
| DPYD *2A homozygous + 5-FU | **AVOID** | ✅ Would prevent fatal toxicity |
| DPYD c.2846A>T + Capecitabine | **50% reduction** | ✅ Would prevent Grade 4 neutropenia |
| TPMT *3A heterozygous + 6-MP | **50% reduction** | ✅ Would prevent myelosuppression |
| UGT1A1 *28/*28 + Irinotecan | **50% reduction** | ✅ Would prevent severe diarrhea |

---

## 📋 What We Need From You (30 minutes)

### Quick Tasks:

1. **Review CPIC Alignment** (10 min)
   - See `CPIC_ALIGNMENT_SUMMARY.md`
   - Confirm our variant-to-phenotype mappings are correct

2. **Review 6 Key Cases** (15 min)
   - See `CONCORDANCE_REVIEW_FORM.md`
   - Mark each as MATCH, MORE CONSERVATIVE, or DISAGREE

3. **Sign Off** (5 min)
   - Complete the sign-off checklist in `SME_REVIEW_PACKAGE.md`

---

## 🔴 Critical Questions Needing Your Input

1. Is 50% dose reduction appropriate for DPYD c.2846A>T heterozygotes?
2. Should DPD-deficient patients EVER receive fluoropyrimidines?
3. Are our alternative drug suggestions (raltitrexed, etc.) appropriate?
4. Any edge cases where our logic could be dangerous?

---

## 📁 Documents Provided

| Document | Purpose | Time to Review |
|----------|---------|----------------|
| `SME_REVIEW_PACKAGE.md` | Complete technical review + sign-off | 20-30 min |
| `CONCORDANCE_REVIEW_FORM.md` | Case-by-case clinical comparison | 15-20 min |
| `CPIC_ALIGNMENT_SUMMARY.md` | Quick reference: CPIC vs Our System | 5-10 min |
| `validation_report.json` | Raw validation data | Reference only |

---

## ✍️ Quick Sign-Off (If Time Limited)

If you only have 5 minutes, please complete this:

```
□ I have reviewed the CPIC alignment summary
□ The dose adjustment logic appears clinically appropriate
□ No obvious safety concerns identified
□ System is acceptable for Research Use Only (RUO)

Signature: _________________ Date: _________

Name: _____________________________________

Credentials: _______________________________
```

---

**Contact:** Alpha (Project Lead)  
**Timeline:** 1-week response requested  
**Status:** 70% Publication Ready → Awaiting SME Sign-Off

---

*Thank you for your time and expertise!* 🙏

